Uterine Corpus Endometrial Carcinoma in Young Women

Authors

  • Caesar Muhammad Wijaya Obstetrics and Gynecology Specialist Education Program, Faculty of Medicine, Andalas University – Dr. M. Djamil Central General Hospital of Padang, West Sumatra, Indonesia
  • Puja Agung Antonius Oncology Gynaecology Division, Department of Obstetrics and Gynaecology, Faculty of Medicine, Andalas University – Dr. M. Djamil Central General Hospital of Padang, West Sumatra, Indonesia
  • Syamel Muhammad Oncology Gynaecology Division, Department of Obstetrics and Gynaecology, Faculty of Medicine, Andalas University –Dr. M. Djamil Central General Hospital of Padang,West Sumatra,Indonesia
  • Mutia Paramadita Anugrah General Practitioner, Faculty of Medicine, Islamic Sultan Agung University, Semarang, Indonesia

DOI:

https://doi.org/10.25077/aoj.9.1.161-166.2025

Keywords:

Uterine Corpus Endometrial Carcinoma, Young Women

Abstract

Introduction : Endometrial carcinoma is a malignant epithelial tumor that forms in the uterus's inner lining, or endometrium. The average age at diagnosis is 61 years, with cases diagnosed after 50 years more than 90%. Endometrial carcinoma is rare in young women, usually defined as occurring under age 50 or menopause, with rare cases occurring under age 40.

Case Report : A 35-year-old woman nulliparous complaints of abdominal pain since 3 months ago and complained of weight loss. Based on the anamnesis, the patient is not married. On physical examination, revealed an area of firmness in the suprapubic region associated with pain on palpation. On ultrasound examination, the uterus was found to be anteflexed, with an inhomogeneous appearance, and a solid cystic mass along the uterus. Adnexa measuring 10.02 x 10.20 x 12.02 cm, vascular scale 4, not clearly defined. The patient was diagnosed with suspected uterine corpus carcinoma.

Result : In this patient, a total hysterectomy and bilateral salpingo-oophorectomy were performed because the patient did not want fertility.

Conclussion : In young women who want to preserve fertility, conservative management is often implemented. But, when fertility-sparing treatment is not considered, the rate of recurrence and progression is considerably low in this case. Ultimately, although fertility-sparing treatments are an attractive alternative to surgery resulting in permanent loss of fertility, unfortunately, they can only be applied in a subset of cases. The standard surgical procedure recommended is a total extra-fascial hysterectomy with bilateral salpingo-oophorectomy.

Keywords: Uterine Corpus Endometrial Carcinoma, Young Women

References

Abu-Rustum, Nadeem et al. “Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.” Journal of the National Comprehensive Cancer Network : JNCCN vol. 21,2 (2023): 181-209. doi:10.6004/jnccn.2023.0006

Siegel, Rebecca L et al. “Cancer statistics, 2022.” CA: a cancer journal for clinicians vol. 72,1 (2022): 7-33. doi:10.3322/caac.21708

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016;66:7–30.

Van den Bosch T, Coosemans A, Morina M, et al. Screening for uterine tumours. Best Pract Res Clin Obstet Gynaecol 2012;26:257–266.

Dinkelspiel HE, Wright JD, Lewin SN, et al. Contemporary clinical man- agement of endometrial cancer. Obstet Gynecol Int 2013;2013:583891.

Satei, Jessica et al. “Endometrial Adenocarcinoma in Young Women: A Case Report and Review of Literature.” Cureus vol. 15,9 e45287. 15 Sep. 2023, doi:10.7759/cureus.45287

Koskas, Martin et al. “Cancer of the corpus uteri: 2021 update.” International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics vol. 155 Suppl 1,Suppl 1 (2021): 45-60. doi:10.1002/ijgo.13866

Mbatani, Nomonde et al. “Uterine sarcomas.” International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics vol. 143 Suppl 2 (2018): 51-58. doi:10.1002/ijgo.12613

Sung, Hyuna et al. “Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.” CA: a cancer journal for clinicians vol. 71,3 (2021): 209-249. doi:10.3322/caac.21660

Agency for Research on Cancer. Cancer tomorrow (website).Accessed January 14, 2021. https://gco.iarc.fr/tomorrow/graphicisotype?type=1&population=900&mode=population&sex=2&- cancer=39&age_group=value&apc_male=0&apc_female=0

Edmondson, R J et al. “Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiative.” Gynecologic oncology vol. 146,2 (2017): 327-333. doi:10.1016/j.ygyno.2017.05.014

Janda, Monika et al. “Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Disease-Free Survival Among Women With Stage I Endometrial Cancer: A Randomized Clinical Trial.” JAMA vol. 317,12 (2017): 1224-1233. doi:10.1001/jama.2017.2068

Leslie KK, Thiel KW, Goodheart MJ, et al. Endometrial cancer. Obstet Gynecol Clin North Am 2012;39:255–268.

Smith RA, Brooks D, Cokkinides V, et al. Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening. CA Cancer J Clin 2013;63: 88–105.

Crivellaro C, Signorelli M, Guerra L, et al. Tailoring systematic lympha- denectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT. Gynecol Oncol 2013;130:306–311.

Antonsen SL, Jensen LN, Loft A, et al. MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer - a multicenter prospec- tive comparative study. Gynecol Oncol 2013;128:300–308.

Bollineni VR, Ytre-Hauge S, Bollineni-Balabay O, et al. High diagnostic value of 18F-FDG PET/CT in endometrial cancer: systematic review and meta-analysis of the literature. J Nucl Med 2016;57:879–885.

Reinhold C, Ueno Y, Akin EA, et al. ACR Appropriateness Criteria pretreatment evaluation and follow-up of endometrial cancer. J Am Coll Radiol 2020;17(Suppl 11):S472–486.

ACOG. Power morcellation and occult malignancy in gynecologic sur- gery. Accessed January 23, 2023. Available at: https://www.sgo.org/wp- content/uploads/2014/04/ACOG_Statement.pdf

U.S. Department of Health and Human Services. FDA discourages use of laparoscopic power morcellation for removal of uterus or uterine fib- roids. Accessed January 23, 2023. Available at: https://www.fda.gov/ NewsEvents/Newsroom/PressAnnouncements/ucm393689.htm

Galaal, Khadra et al. “Laparoscopy versus laparotomy for the management of early stage endometrial cancer.” The Cochrane database of systematic reviews vol. 10,10 CD006655. 31 Oct. 2018, doi:10.1002/14651858.CD006655.pub3

Marni H, Ferry F, Utama BI. ANDALAS OBSTETRICS AND GYNECOLOGY JOURNAL Bicornu Uterus. Ruang Redaksi Andalas Obstet Gynecol J. 2018;2(2):25127. doi:https://doi.org/10.25077/aoj.2.2.115-118.2018

Milano DC, Muhammad, SpOG(K)-Onkogin D dr. S. Uterine Rupture due to Gestational Trophoblastic Neoplasia on Nulliparous Woman : A Case Report. Andalas Obstet Gynecol J. 2022;6(2):198-202. doi:10.25077/aoj.6.2.198-202.2022

Downloads

Published

2025-01-22

How to Cite

Caesar Muhammad Wijaya, Antonius, P. A. ., Syamel Muhammad, & Anugrah, M. P. . (2025). Uterine Corpus Endometrial Carcinoma in Young Women. Andalas Obstetrics And Gynecology Journal, 9(1), 161–166. https://doi.org/10.25077/aoj.9.1.161-166.2025

Issue

Section

CASE REPORT